“Growing Adoption of Biological Larvicides”
A key trend driving growth in the larvicides market is the increasing adoption of biological larvicides. These environmentally friendly solutions use natural agents such as bacteria (Bacillus thuringiensis israelensis) to target mosquito larvae without harming other organisms. With rising awareness of the adverse effects of chemical larvicides on ecosystems and human health, biological alternatives are gaining traction. For instance, the introduction of VectoBac by Valent BioSciences, a bio-larvicide, has been widely implemented in mosquito control programs globally. This trend is fueled by growing regulatory support for sustainable pest control measures, further propelling market growth in agricultural and public health applications.
